Wassana Yantasee

6PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor Microenvironment.

|Dec 21, 2023
Nanotechnology Applications in Breast Cancer Immunotherapy.

Ruijie Wang, Pramod Kumar, Moataz Reda

|Jul 23, 2022
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.

Moataz Reda, Worapol Ngamcherdtrakul, Molly A Nelson

|Jan 27, 2022
Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis.

Worapol Ngamcherdtrakul, Daniel S Bejan, William Cruz-Muñoz

|Jun 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response.

Worapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson

|May 08, 2021
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Molly A Nelson, Worapol Ngamcherdtrakul, Shiuh-Wen Luoh

Pageof 1

Frequent Collaborators

2 joint publications

Gordon Mills

2 joint publications

Worapol Ngamcherdtrakul

1 joint publications

Akash Bindal

1 joint publications

Joe W Gray